A longevity test for men typically examines biomarkers such as telomere length (TERT gene), thyroid markers (TSH, free T4, free T3), and genetic variants linked to aging. The evidence is mixed: TSH/fT4/fT3 are well-established clinical markers (guideline-supported), but direct-to-consumer telomere tests often overclaim. Telomerase (TERT) maintains chromosome ends, but lifestyle lengthening is unproven – observational studies show only small effects. Genetic variants in DIO2, TSHR, or FOXE1 explain <1% of TSH variation and have no individual clinical utility. Moreover, most 'longevity' markers lack randomized trial data. Bottom line: basic thyroid screening is useful, but most DNA-based 'aging clocks' or telomere tests are not sufficiently validated. Seek medical advice before purchasing expensive tests or changing behavior.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-00aca6745ed9f730ac362431